WHO Chief: War in Ukraine will ‘Reverberate for Many Years to Come’ 13/09/2022 Rossella Tercatin TEL AVIV – Russia’s invasion of Ukraine will likely have long-lasting impacts on public health in Europe, both directly and in terms of global challenges related to food security and climate. That was among the key messages from the World Health Organization’s Director-General Dr Tedros Adhanom Ghebreyesus and Regional Director for Europe Hans Kluge at […] Continue reading -> New Malaria Vaccine With 75% Efficacy is a Potential Game-Changer 10/09/2022 Paul Adepoju A new R21/Matrix-M malaria vaccine shows 75% efficacy in a Phase2b trial – a potentially game-changing result compared to the WHO-approved RTS,S/AS01 (RTS,S) vaccine. The WHO has said it will continue with the rollout of its approved RTS,S vaccine, despite the promise of a new malaria vaccine candidate, the R21/Matrix-M, that shows an efficacy of […] Continue reading -> COVID Threatens Meningitis Fight in Africa 09/09/2022 Paul Adepoju & John Heilprin The COVID-19 pandemic delayed plans to vaccinate more than 50 million African children with doses of MenAfriVac, a vaccine designed for the African meningitis belt. That could undo the progress in controlling a lethal form of meningitis in Africa, the World Health Organization warns. Until 12 years ago, meningitis type A made up 90% of […] Continue reading -> 39,000 Test Kits for Africa – No Single Vaccine Dose, No Antiviral Treatment 09/09/2022 Paul Adepoju More than a month after declaring Monkeypox a public health emergency of international concern (PHEIC), WHO’s Africa Region has only received 39,000 test kits for the virus – while vaccines and treatments remain unavailable on the continent where the disease is endemic and often more deadly. That was the key message emerging out of a […] Continue reading -> Fighting the Scourge of Fake Medicines: Global Fund Replenishment is Moment of Truth 09/09/2022 Adam Aspinall The upcoming Global Fund Replenishment drive, 19-21 September, will be critical to holding onto and advancing progress against infectious diseases in multiple ways – among them ensuring the flow of quality-assured medicines to low-income countries and fighting falsified and substandard medicines that can comprise up to 70% of drugs on the market in some parts […] Continue reading -> Pan-American Region Secures First Monkeypox Vaccines Deal 08/09/2022 Raisa Santos & Stefan Anderson In an effort to prevent the spread of monkeypox, the Pan American Health Organization (PAHO) signed an agreement with Bavarian Nordic to obtain 100,000 vaccine doses for Latin America and the Caribbean. That will allow PAHO to start delivering the doses to the 12 countries that requested them in September. The agreement will make the […] Continue reading -> Fraction of US Monkeypox Cases With No Recent MSM Contact Continues to Increase in Silent Spread to Other Communities 02/09/2022 Raisa Santos The fraction of monkeypox cases with no recent contact with men who have sex with men (MSM) continues to rise in the US – accounting for one-third of cases – suggesting a silent spread of the virus to other communities. Men with recent MSM contact accounted for 65.78% of cases as of 20 August, according […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> First African Manufactured Medicine to Prevent Malaria in Pregnant Women and Infants Quality-Approved by WHO 26/08/2022 Raisa Santos Kenyan manufacturer Universal Corporation LTD (UCL) has become the first African manufacturer to be issued a World Health Organization quality certification of a key antimalarial drug used to prevent infection in pregnant women and children. This certification, known as prequalification, will enable UCL to support regional efforts to combat malaria through local production of high-quality […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New Malaria Vaccine With 75% Efficacy is a Potential Game-Changer 10/09/2022 Paul Adepoju A new R21/Matrix-M malaria vaccine shows 75% efficacy in a Phase2b trial – a potentially game-changing result compared to the WHO-approved RTS,S/AS01 (RTS,S) vaccine. The WHO has said it will continue with the rollout of its approved RTS,S vaccine, despite the promise of a new malaria vaccine candidate, the R21/Matrix-M, that shows an efficacy of […] Continue reading -> COVID Threatens Meningitis Fight in Africa 09/09/2022 Paul Adepoju & John Heilprin The COVID-19 pandemic delayed plans to vaccinate more than 50 million African children with doses of MenAfriVac, a vaccine designed for the African meningitis belt. That could undo the progress in controlling a lethal form of meningitis in Africa, the World Health Organization warns. Until 12 years ago, meningitis type A made up 90% of […] Continue reading -> 39,000 Test Kits for Africa – No Single Vaccine Dose, No Antiviral Treatment 09/09/2022 Paul Adepoju More than a month after declaring Monkeypox a public health emergency of international concern (PHEIC), WHO’s Africa Region has only received 39,000 test kits for the virus – while vaccines and treatments remain unavailable on the continent where the disease is endemic and often more deadly. That was the key message emerging out of a […] Continue reading -> Fighting the Scourge of Fake Medicines: Global Fund Replenishment is Moment of Truth 09/09/2022 Adam Aspinall The upcoming Global Fund Replenishment drive, 19-21 September, will be critical to holding onto and advancing progress against infectious diseases in multiple ways – among them ensuring the flow of quality-assured medicines to low-income countries and fighting falsified and substandard medicines that can comprise up to 70% of drugs on the market in some parts […] Continue reading -> Pan-American Region Secures First Monkeypox Vaccines Deal 08/09/2022 Raisa Santos & Stefan Anderson In an effort to prevent the spread of monkeypox, the Pan American Health Organization (PAHO) signed an agreement with Bavarian Nordic to obtain 100,000 vaccine doses for Latin America and the Caribbean. That will allow PAHO to start delivering the doses to the 12 countries that requested them in September. The agreement will make the […] Continue reading -> Fraction of US Monkeypox Cases With No Recent MSM Contact Continues to Increase in Silent Spread to Other Communities 02/09/2022 Raisa Santos The fraction of monkeypox cases with no recent contact with men who have sex with men (MSM) continues to rise in the US – accounting for one-third of cases – suggesting a silent spread of the virus to other communities. Men with recent MSM contact accounted for 65.78% of cases as of 20 August, according […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> First African Manufactured Medicine to Prevent Malaria in Pregnant Women and Infants Quality-Approved by WHO 26/08/2022 Raisa Santos Kenyan manufacturer Universal Corporation LTD (UCL) has become the first African manufacturer to be issued a World Health Organization quality certification of a key antimalarial drug used to prevent infection in pregnant women and children. This certification, known as prequalification, will enable UCL to support regional efforts to combat malaria through local production of high-quality […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
COVID Threatens Meningitis Fight in Africa 09/09/2022 Paul Adepoju & John Heilprin The COVID-19 pandemic delayed plans to vaccinate more than 50 million African children with doses of MenAfriVac, a vaccine designed for the African meningitis belt. That could undo the progress in controlling a lethal form of meningitis in Africa, the World Health Organization warns. Until 12 years ago, meningitis type A made up 90% of […] Continue reading -> 39,000 Test Kits for Africa – No Single Vaccine Dose, No Antiviral Treatment 09/09/2022 Paul Adepoju More than a month after declaring Monkeypox a public health emergency of international concern (PHEIC), WHO’s Africa Region has only received 39,000 test kits for the virus – while vaccines and treatments remain unavailable on the continent where the disease is endemic and often more deadly. That was the key message emerging out of a […] Continue reading -> Fighting the Scourge of Fake Medicines: Global Fund Replenishment is Moment of Truth 09/09/2022 Adam Aspinall The upcoming Global Fund Replenishment drive, 19-21 September, will be critical to holding onto and advancing progress against infectious diseases in multiple ways – among them ensuring the flow of quality-assured medicines to low-income countries and fighting falsified and substandard medicines that can comprise up to 70% of drugs on the market in some parts […] Continue reading -> Pan-American Region Secures First Monkeypox Vaccines Deal 08/09/2022 Raisa Santos & Stefan Anderson In an effort to prevent the spread of monkeypox, the Pan American Health Organization (PAHO) signed an agreement with Bavarian Nordic to obtain 100,000 vaccine doses for Latin America and the Caribbean. That will allow PAHO to start delivering the doses to the 12 countries that requested them in September. The agreement will make the […] Continue reading -> Fraction of US Monkeypox Cases With No Recent MSM Contact Continues to Increase in Silent Spread to Other Communities 02/09/2022 Raisa Santos The fraction of monkeypox cases with no recent contact with men who have sex with men (MSM) continues to rise in the US – accounting for one-third of cases – suggesting a silent spread of the virus to other communities. Men with recent MSM contact accounted for 65.78% of cases as of 20 August, according […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> First African Manufactured Medicine to Prevent Malaria in Pregnant Women and Infants Quality-Approved by WHO 26/08/2022 Raisa Santos Kenyan manufacturer Universal Corporation LTD (UCL) has become the first African manufacturer to be issued a World Health Organization quality certification of a key antimalarial drug used to prevent infection in pregnant women and children. This certification, known as prequalification, will enable UCL to support regional efforts to combat malaria through local production of high-quality […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
39,000 Test Kits for Africa – No Single Vaccine Dose, No Antiviral Treatment 09/09/2022 Paul Adepoju More than a month after declaring Monkeypox a public health emergency of international concern (PHEIC), WHO’s Africa Region has only received 39,000 test kits for the virus – while vaccines and treatments remain unavailable on the continent where the disease is endemic and often more deadly. That was the key message emerging out of a […] Continue reading -> Fighting the Scourge of Fake Medicines: Global Fund Replenishment is Moment of Truth 09/09/2022 Adam Aspinall The upcoming Global Fund Replenishment drive, 19-21 September, will be critical to holding onto and advancing progress against infectious diseases in multiple ways – among them ensuring the flow of quality-assured medicines to low-income countries and fighting falsified and substandard medicines that can comprise up to 70% of drugs on the market in some parts […] Continue reading -> Pan-American Region Secures First Monkeypox Vaccines Deal 08/09/2022 Raisa Santos & Stefan Anderson In an effort to prevent the spread of monkeypox, the Pan American Health Organization (PAHO) signed an agreement with Bavarian Nordic to obtain 100,000 vaccine doses for Latin America and the Caribbean. That will allow PAHO to start delivering the doses to the 12 countries that requested them in September. The agreement will make the […] Continue reading -> Fraction of US Monkeypox Cases With No Recent MSM Contact Continues to Increase in Silent Spread to Other Communities 02/09/2022 Raisa Santos The fraction of monkeypox cases with no recent contact with men who have sex with men (MSM) continues to rise in the US – accounting for one-third of cases – suggesting a silent spread of the virus to other communities. Men with recent MSM contact accounted for 65.78% of cases as of 20 August, according […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> First African Manufactured Medicine to Prevent Malaria in Pregnant Women and Infants Quality-Approved by WHO 26/08/2022 Raisa Santos Kenyan manufacturer Universal Corporation LTD (UCL) has become the first African manufacturer to be issued a World Health Organization quality certification of a key antimalarial drug used to prevent infection in pregnant women and children. This certification, known as prequalification, will enable UCL to support regional efforts to combat malaria through local production of high-quality […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Fighting the Scourge of Fake Medicines: Global Fund Replenishment is Moment of Truth 09/09/2022 Adam Aspinall The upcoming Global Fund Replenishment drive, 19-21 September, will be critical to holding onto and advancing progress against infectious diseases in multiple ways – among them ensuring the flow of quality-assured medicines to low-income countries and fighting falsified and substandard medicines that can comprise up to 70% of drugs on the market in some parts […] Continue reading -> Pan-American Region Secures First Monkeypox Vaccines Deal 08/09/2022 Raisa Santos & Stefan Anderson In an effort to prevent the spread of monkeypox, the Pan American Health Organization (PAHO) signed an agreement with Bavarian Nordic to obtain 100,000 vaccine doses for Latin America and the Caribbean. That will allow PAHO to start delivering the doses to the 12 countries that requested them in September. The agreement will make the […] Continue reading -> Fraction of US Monkeypox Cases With No Recent MSM Contact Continues to Increase in Silent Spread to Other Communities 02/09/2022 Raisa Santos The fraction of monkeypox cases with no recent contact with men who have sex with men (MSM) continues to rise in the US – accounting for one-third of cases – suggesting a silent spread of the virus to other communities. Men with recent MSM contact accounted for 65.78% of cases as of 20 August, according […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> First African Manufactured Medicine to Prevent Malaria in Pregnant Women and Infants Quality-Approved by WHO 26/08/2022 Raisa Santos Kenyan manufacturer Universal Corporation LTD (UCL) has become the first African manufacturer to be issued a World Health Organization quality certification of a key antimalarial drug used to prevent infection in pregnant women and children. This certification, known as prequalification, will enable UCL to support regional efforts to combat malaria through local production of high-quality […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Pan-American Region Secures First Monkeypox Vaccines Deal 08/09/2022 Raisa Santos & Stefan Anderson In an effort to prevent the spread of monkeypox, the Pan American Health Organization (PAHO) signed an agreement with Bavarian Nordic to obtain 100,000 vaccine doses for Latin America and the Caribbean. That will allow PAHO to start delivering the doses to the 12 countries that requested them in September. The agreement will make the […] Continue reading -> Fraction of US Monkeypox Cases With No Recent MSM Contact Continues to Increase in Silent Spread to Other Communities 02/09/2022 Raisa Santos The fraction of monkeypox cases with no recent contact with men who have sex with men (MSM) continues to rise in the US – accounting for one-third of cases – suggesting a silent spread of the virus to other communities. Men with recent MSM contact accounted for 65.78% of cases as of 20 August, according […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> First African Manufactured Medicine to Prevent Malaria in Pregnant Women and Infants Quality-Approved by WHO 26/08/2022 Raisa Santos Kenyan manufacturer Universal Corporation LTD (UCL) has become the first African manufacturer to be issued a World Health Organization quality certification of a key antimalarial drug used to prevent infection in pregnant women and children. This certification, known as prequalification, will enable UCL to support regional efforts to combat malaria through local production of high-quality […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Fraction of US Monkeypox Cases With No Recent MSM Contact Continues to Increase in Silent Spread to Other Communities 02/09/2022 Raisa Santos The fraction of monkeypox cases with no recent contact with men who have sex with men (MSM) continues to rise in the US – accounting for one-third of cases – suggesting a silent spread of the virus to other communities. Men with recent MSM contact accounted for 65.78% of cases as of 20 August, according […] Continue reading -> US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> First African Manufactured Medicine to Prevent Malaria in Pregnant Women and Infants Quality-Approved by WHO 26/08/2022 Raisa Santos Kenyan manufacturer Universal Corporation LTD (UCL) has become the first African manufacturer to be issued a World Health Organization quality certification of a key antimalarial drug used to prevent infection in pregnant women and children. This certification, known as prequalification, will enable UCL to support regional efforts to combat malaria through local production of high-quality […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Food and Drug Administration Approves Omicron-Targeting COVID-19 Boosters for Fall 31/08/2022 Raisa Santos The US Food and Drug Administration (FDA) granted emergency use authorization (EUA) to two Omicron-targeting booster vaccines on Wednesday as it anticipates the potential rise of COVID-19 cases in its fall and spring. The boosters, one by Moderna and the other by Pfizer-BioNTech, are bivalent vaccines, or “updated boosters”, that are designed to protect against […] Continue reading -> Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> First African Manufactured Medicine to Prevent Malaria in Pregnant Women and Infants Quality-Approved by WHO 26/08/2022 Raisa Santos Kenyan manufacturer Universal Corporation LTD (UCL) has become the first African manufacturer to be issued a World Health Organization quality certification of a key antimalarial drug used to prevent infection in pregnant women and children. This certification, known as prequalification, will enable UCL to support regional efforts to combat malaria through local production of high-quality […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Poor Vaccines Coverage in Pandemic Blamed on Multiple Barriers 26/08/2022 John Heilprin & Dann Okoth Some of the biggest obstacles to expanded vaccines coverage in the world’s poorest and most conflict-ridden nations are lack of cold chain storage, unpredictable supply chains, and transport barriers, not claims of “vaccine hesitancy” in the Global South, according to a new report. The picture of the steep challenges faced by 14 nations during the […] Continue reading -> First African Manufactured Medicine to Prevent Malaria in Pregnant Women and Infants Quality-Approved by WHO 26/08/2022 Raisa Santos Kenyan manufacturer Universal Corporation LTD (UCL) has become the first African manufacturer to be issued a World Health Organization quality certification of a key antimalarial drug used to prevent infection in pregnant women and children. This certification, known as prequalification, will enable UCL to support regional efforts to combat malaria through local production of high-quality […] Continue reading -> Posts navigation Older postsNewer posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
First African Manufactured Medicine to Prevent Malaria in Pregnant Women and Infants Quality-Approved by WHO 26/08/2022 Raisa Santos Kenyan manufacturer Universal Corporation LTD (UCL) has become the first African manufacturer to be issued a World Health Organization quality certification of a key antimalarial drug used to prevent infection in pregnant women and children. This certification, known as prequalification, will enable UCL to support regional efforts to combat malaria through local production of high-quality […] Continue reading -> Posts navigation Older postsNewer posts